Prospective Cohort Study for the Real - Life Effectiveness Evaluation of GlycOpyrronium With IndacatERol Combination in the Management of COPD in Canada (POWER Study)

PHASE4CompletedINTERVENTIONAL

Enrollment

401

Participants

Timeline

Start Date

August 27, 2014

Primary Completion Date

April 5, 2017

Study Completion Date

April 5, 2017

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG

Glycopyrronium /Indacaterol maleate

Glycopyrronium 50mcg/Indacaterol maleate 110mcg once daily by a breezhaler device

Trial Locations (1)

Novartis Investigative Site, Saint-Charles-Borromée